Abstract: A radiating phase-shifting cell is designed to favour the excitation of an equivalent resonance of the “slot” type in a first part of the phase cycle, and to favour an equivalent resonance of the “microstrip” type in a second part of the phase cycle. This property notably allows the bandwidth of the phase-shifting cells to be optimized. A phase range of 360° can in effect be segmented into two sub-ranges of around 180°. This segmentation into two sub-ranges is made possible by the complementarity of the resonant modes of the slot or microstrip type. The radiating phase-shifting cell is notably applicable to reflector arrays for an antenna designed to be installed on a space craft such as a telecommunications satellite or on a terrestrial terminal for satellite telecommunications or broadcasting systems.

Abstract: The invention relates to a copolyamide comprising units resulting from the polycondensation reaction of the following precursors: terephthalic acid (a), an aliphatic diamine (b) comprising x carbon atoms, x being an integer between 6 and 22, and an aminocarboxylic acid and/or a lactam (c) comprising a main chain and at least one linear or branched alkyl branching, the total number of carbon atoms of the aminocarboxylic acid and/or of the lactam (c) being between 12 and 36. The invention also relates to the process for preparing said copolyamide and to a composition comprising such a copolyamide.

Abstract: The present invention relates to positively charged particles consisting of a chitosan polyelectrolyte complex and of an anionic polymer, characterized in that the chitosan has a degree of acetylation (DA) in the range of 35 to 49% and a mean molar mass by weight (Mw) in the range of 55 to 150 kg/mol, as well as to a method for preparing same.

Abstract: The invention relates to novel biocompatible hybrid nanoparticles of very small size, useful in particular for diagnostics and/or therapy. The purpose of the invention is to offer novel nanoparticles which are useful in particular as contrast agents in imaging (e.g. MRI) and/or in other diagnostic techniques and/or as therapeutic agents, which give better performance than the known nanoparticles of the same type and which combine both a small size (for example less than 20 nm) and a high loading with metals (e.g. rare earths), in particular so as to have, in imaging (e.g. MRI), strong intensification and a correct response (increased relaxivity) at high frequencies.

Abstract: A device for detecting and quantifying a force applied on a surface comprising a test specimen, an electrically insulating substrate, a first electrode bound to the substrate, a second electrode, an assembly of conductive or semi-conductive nanoparticles in contact with the two electrodes, and a measurement device. The measurement device provides proportional information with respect to an electrical property of the nanoparticles assembly. The electrical property is measured between the first and second electrode. The test specimen is the nanoparticles assembly itself and the electrical property is sensitive to the distance between the nanoparticles of the assembly. The invention uses the nanoparticles assembly itself as a test specimen and allows a force to be quantified even if the nanoparticles assembly is deposited on a rigid substrate.

Abstract: The invention relates to biochips 1 comprising a substrate 2, wherein said substrate comprises at the surface thereof isolated regions 3 for the anchoring of a nucleic acid molecule, said isolated regions having an area of less than 1 ?m2, and the space 4 between two isolated regions being at least equal to the square root of the value of said area of said isolated regions.

Abstract: The invention relates to a structure comprising an n-type substrate (1) having a bottom surface (10) and a top surface (11), a drain (D) contacting the bottom surface (10) of the substrate (1), a first n-type semiconductor region (2) having a top surface (21) provided with a contact area (210), a source (S) contacting the contact area (210), and a second p-type semiconductor region (3) arranged inside the first semiconductor region (2) and defining first and second conduction channels (C1, C2) between the drain and the source, characterized in that said structure comprises first and second metal gratings (G1, G2), each of which has a portion (40, 71) contacting the first semiconductor region (2) so as to form a Schottky junction.

Abstract: The present invention relates, inter alia, to recombinant Gram-positive Clostridia host cells for producing solvents, fuels and/or chemical intermediates, and preferably ethanol, from plant cell walls comprising: (a) at least one nucleic acid encoding a plant cell wall degrading enzyme, wherein the host cells produce and secrete the plant cell wall degrading enzyme, (b) at least one nucleic acid encoding an enzyme that converts pyruvate to acetaldehyde and at least one nucleic acid encoding an enzyme that converts acetaldehyde to ethanol wherein the host cell is capable of expressing said nucleic acid, and, (c) a mutation in at least one nucleic acid encoding for an enzyme in a metabolic pathway which produces a metabolite other than acetaldehyde from pyruvate or ethanol from acetaldehyde, such that the mutation results in a reduced production of the metabolite.

Abstract: The present invention relates to a method for preparing, on a silicon wafer, an n+pp+ or p+nn+ structure which includes the following consecutive steps: a) on a p or n silicon wafer (1), which includes a front surface (8) and a rear surface (9), a layer of boron-doped silicon oxide (BSG) (2) is formed on the rear surface (9) by PECVD, followed by a SiOx diffusion barrier (3); b) a source of phosphorus is diffused such that the phosphorus and the boron co-diffuse and in order also to form: on the front surface (8) of the wafer obtained at the end of step a), a layer of phosphorus-doped silicon oxide (PSG) (4) and an n+ doped area (5); and on the rear surface of the wafer obtained at the end of step a), a boron-rich area (BRL) (6), as well as a p+ doped area (7); c) the layers of BSG (2) and PSG (4) oxides and SiOx (3) are removed, the BRL (6) is oxidised and the layer resulting from said oxidation is removed.

Abstract: A method of nano-structuration of a thin film of electret polymer, called “electric nano-impression” method, in which a surface of a mould, called the structuration surface, including nanometric relief patterns, is placed in contact with at least one part of a free surface, called the treated surface of the thin film of electret polymer, nanometric patterns are formed, corresponding to the negative of the structuration patterns of the mould, in the thin film of electret polymer, by exerting a pressure of the structuration surface on the surface of the thin film of electret polymer, an electric voltage is applied between the structuration surface and the rear face of the film for a predetermined duration T2 suitable for inducing, after removal of the electric voltage applied, a differential distribution of electrostatic charges between the tops and the bottoms of the nanometric patterns formed in the thin electret polymer film.

Abstract: The invention relates to a method for preparing a composite material comprising a polymeric matrix and a filler consisting in ion exchange inorganic particles, comprising a step for synthesis in situ of said particles within the polymeric matrix.

Abstract: The invention concerns a gem-difluorinated C-glycopeptide compound of formula (I) in which N is an integer between 1 and 5, R4=H, AA1, AA1-AA2 and R5=OH, AA1, AA1, AA2, with AA1, and AA2 are independents groups and represent amino acids with a non-functionalized side chain and R1, R2, R3 are independent groups and one of them is equal to formula (II), in which n is an integer between 3 and 4, Y, Y? are independent groups in which Y, Y?=H, OR, N3, NR?R?, SR??, where R=H, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tert-butyldiphenylsilyl, acetate group, R?, R???H, alkyl, allyl, benzyl, tosylate group, C(?O)-alkyl, C(?O)?Bn, R??=H, alkyl, acetate group, R6 is notably a group H, CH3, CH2OH, CH2-Glycoside group, CH2-OGP in which GP is a protector group such as an alkyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, tertbutyldiphenylsilyl, acetate group,; and R7=OH, OGP?, NH2, N3, NHGP?, NGP?GP? in which GP? and GP? is or not a protector group such as an alkyl, benzyl, trimethylsilyl, tertbutyldimethyl

Abstract: The invention concerns hybrid nanoparticles containing: a nanosphere, of mean diameter included in the range from 2 to 9 nm, of which at least 90% by weight consists of Ln2O3 where Ln represents a rare earth, optionally doped with a rare earth or an actinide, or a mixture of rare earths, or a rare earth and actinide mixture, in which at least 50% of the metal ions are rare earth ions, a coating around the nanosphere chiefly consisting of functionalized polysiloxane, having a mean thickness included in the range from 0.5 to 10 nm, preferably greater than 2 nm and no more than 10 nm, and at least one biological ligand grafted by covalent bonding to the polysiloxane coating and their method of preparation.

Abstract: An interconnected array of reconfigurable logic cells which carry out at least one logic function, externally connected to peripheral connection network equipped with switch boxes and connected to programmable input/output blocks. The logic cells are distributed in a first dimension in rows i with i=1 to d and a second dimension in columns j with j=1 to w, with d?2 and w=2 or d=2 and w?2, each logic cell including a second input, a second input, a first output and a second output, the first input of each logic cell and the first output of each logic cell being connected to the connection network, the second input and the second output of each logic cell being connected to other different column and row logic cells except for the first and last rows or columns for d>2 or w>2 respectively.

Abstract: Compounds of formula (I): wherein: R1 represents a hydrogen atom or a group of formula COR4, or R1 represents a group of formula (A): R2 represents a group of formula NR5R6, or R2 represents a nitrogen-containing heterocyclic group, an aryl group or a heteroaryl group, R3 represents a hydrogen atom or an alkyl group, m represents an integer between 1 and 6 inclusive, n represents 0, 1 or 2, their optical isomers, and also addition salts thereof with a pharmaceutically acceptable acid. Medicinal products containing the same which are useful in treating and/or preventing thrombotic events.

Abstract: A method for recovering inert or living microparticles in which a rising liquid column is set up under negative pressure of an aqueous effluent that includes inert or living microparticles, and a foam is separated at the top of the column into a multiphase effluent enriched with inert or living microparticles relative to the aqueous effluent and into a mostly liquid effluent depleted of inert or living microparticles relative to the aqueous effluent. The invention also concerns the different applications of this method and an installation implementing this method.

Abstract: Robotized installation for the guided and controlled positioning and movement of a component or an instrument for diagnostic or surgical treatment at or around the head of a patient, whereby the installation includes a robotic device that forms a serial kinematic chain and carries component or instrument at its free and position-controlled end. The robotic device has three kinematic sub-assemblies that are mutually combined in series and include, a first sub-assembly in the form of a rotary-articulation mechanism corresponding to a serial-type, spherical kinematic arrangement with three degrees of freedom, a second sub-assembly in the form of a mechanism with linear translation along an axis, and a third sub-assembly in the form of a second rotary-articulation mechanism, integral with the moving part of the second sub-assembly and also corresponding to a serial-type spherical kinematic arrangement with three degrees of freedom.

Abstract: A circuit for the ultra-quick control of an optoelectronic device, includes a generator of voltage pulses having a pulse duration of less than 400 ps, and a circuit (17) for shaping control pulses including: an output suitable for being connected in series to a line terminal (13) of the optoelectronic device, and an input connected to the voltage-pulse generator and receiving the voltage pulses formed by the latter, between a terminal of the input and a terminal of the output, mounted in parallel in relation to one another: a first branch (20) made up of a passive rectifier circuit (22a, 22b) having non-zero threshold voltage and, in series in the first branch in forward direction relative to the line terminal (13) of the optoelectronic device, a second capacitive branch (21).

Abstract: The present invention relates to a recombinant process for the production of truncated or mutated dextransucrases while conserving the enzymatic activity or their specificity in the synthesis of the ?-1,6 bonds. The present invention relates to nucleic acid sequences of truncated or mutated dextransucrases, vectors containing the nucleic acid sequences and host cells transformed by sequences encoding truncated or mutated dextransucrases. In another aspect, the invention concerns a method for producing, in a recombinant manner, truncated or mutated dextransucrases which conserve their enzymatic activity or which conserve their specificity in the synthesis of ?-1,6 bonds and can produce, from saccharose, dextrans with high molar mass and modified rheological properties compared with the properties of dextran obtained with the native enzyme and isomalto-oligosaccharides with a controlled molar mass and dextrans.

Abstract: The present invention relates to a process for the total synthesis of epicocconone analogs of formula (I): The invention also relates to novel epicocconone analogs.